SCHEMBL6582691

SCHEMBL6582691

Cc1ccc(N)c(Br)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.43
ALDH1A1 P00352 7/20 0.41
TDP1 Q9NUW8 4/20 0.41
TSHR P16473 3/20 0.41
POLB P06746 2/20 0.36
CASP1 P29466 1/20 0.36
CD44 P16070 1/20 0.36
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
BLM P54132 1/20 0.35
MCL1 Q07820 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.35
PLA2G7 Q13093 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23604396 0.81 CYP3A4 (0.43) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL10603666 0.80 ALDH1A1 (0.43) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL3884369 0.79 CYP3A4 (0.50) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL10798531 0.77 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL4448667 0.75 ALDH1A1 (0.36) CYP3A4ALDH1A1
SCHEMBL10990892 0.75 TSHR (0.39) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL10990726 0.75 ALDH1A1 (0.36) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL31569267 0.75 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL3671149 0.75 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TSHRPOLB
SCHEMBL29702059 0.75 ALDH1A1 (0.37) CYP3A4ALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155012-B1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES CANCER REC TECH LTD (GB) 2004-04-14 EP disclosed
US-6699861-B1 ANTI-CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2004-03-02 US disclosed
EP-1155012-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES Cancer Research Ventures Limited (GB) 2001-11-21 EP disclosed
WO-2000050417-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES CANCER RESEARCH VENTURES LIMITED (GB) 2000-08-31 WO disclosed